| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.094 | 0.09 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.07 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |